CD68 and neoplasm: The analysis of the CD105+ MVD, Try+ McMD and CD68+ MphMD values revealed no significant differences, but there were variations in their distribution when the data were grouped into tumor topography (intratumoral vs. advancing edge), grade and tumor stage subcategories.